Rate My Professor Terrill Bravender

Terrill Bravender, MD, MPH, serves as the David S. Rosen M.D. Legacy Professor in Adolescent Medicine, Clinical Professor of Pediatrics, and Clinical Professor of Psychiatry at the University of Michigan Medical School. In the Department of Pediatrics, he holds the positions of Division Director of Adolescent Medicine, Associate Chair for Faculty Affairs, Executive Director of the Mott Comprehensive Eating Disorders Program, and Co-Medical Director of the University of Michigan Adolescent Health Initiative. A graduate of the University of Michigan, where he earned his BS and MD degrees, Dr. Bravender completed his pediatrics residency and chief residency at Duke University School of Medicine and his clinical fellowship in Adolescent Medicine at Boston Children’s Hospital. He also holds an MPH from Harvard University. Before returning to the University of Michigan in 2014 to establish the Division of Adolescent Medicine, he held faculty appointments at Harvard University, Duke University, and Ohio State University. Board-certified in Pediatrics and Adolescent Medicine, his clinical practice encompasses adolescent eating disorders including anorexia nervosa, bulimia nervosa, and avoidant/restrictive food intake disorder, as well as adolescent depression, anxiety disorders, menstrual disorders, and the intersection of mental and physical health concerns.

Dr. Bravender’s research interests center on the medical management of adolescent eating disorders, treatment outcomes in adolescent eating disorders, the impact of mental health on physical health conditions in adolescents, workforce equity in healthcare, and patient-centered communication. He has published more than 100 articles, book chapters, and books in the field of adolescent health and eating disorders. Notable recent publications include “Advancements in Inpatient Medical Management of Malnutrition in Children and Adolescents with Restrictive Eating Disorders” (Stoody VB, Garber AK, Miller CA, Bravender T; Journal of Pediatrics, 2023), “Adolescent eating disorder treatment outcomes of an in-person partial hospital program versus a virtual intensive outpatient program” (Van Huysse JL, Prohaska N, Miller C, Jary J, Sturza J, Etsell K, Bravender T; International Journal of Eating Disorders, 2023), “Estimating Goal Weights in Adolescents with Anorexia Nervosa and Atypical Anorexia Nervosa: Comparison of the Median BMI and Historical BMI Percentile” (Jary JM, Winnie SL, Bravender T, Prohaska N, Van Huysse JL; Journal of Adolescent Health, 2023), and “Multidisciplinary Inpatient Care for Medically Compromised Youth and Young Adults With Eating Disorders” (Pierce J, Stoody VB, Cwynar C, Khan S, Bravender T; Psychiatric Times, 2024). He co-authored a clinical practice guideline for inpatient medical management of malnutrition in children and adolescents with restrictive eating disorders. Dr. Bravender maintains active involvement with the Society for Adolescent Health and Medicine, Society for Pediatric Research, and American Board of Pediatrics.